help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kiebzak, G. M.
Right arrow Articles by Meyer, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiebzak, G. M.
Right arrow Articles by Meyer, R. A., Jr

Endocrinology, Vol 111, 650-652, Copyright © 1982 by Endocrine Society

ARTICLES

Secondary hyperparathyroidism in X-linked hypophosphatemic mice

GM Kiebzak, BA Roos and RA Meyer Jr

Plasma parathyroid hormone (PTH) was measured in adult, age-matched, intact normal mice and Hyp male mice (n = 11/genotype). Hyp mice are an animal model for the human disease X-linked hypophosphatemia. A RIA was used which detects intact and carboxyl-terminal fragments of PTH. Hyp mice were found to have significantly higher plasma PTH levels (0.21 +/- 0.03 ng bovine PTH eq/ml) than normal mice (0.04 +/- 0.03 ng/ml; P less than 0.01). This hyperparathyroidism in the slightly hypocalcemic, osteomalacic Hyp mice may be the result of skeletal resistance to endogenous PTH and may contribute to their characteristically elevated renal excretion of phosphate and urinary cAMP


This article has been cited by other articles:


Home page
 EndocrinologyHome page
X. Bai, D. Miao, D. Goltzman, and A. C. Karaplis
Early Lethality in Hyp Mice with Targeted Deletion of Pth Gene
Endocrinology, October 1, 2007; 148(10): 4974 - 4983.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
X. Bai, D. Miao, J. Li, D. Goltzman, and A. C. Karaplis
Transgenic Mice Overexpressing Human Fibroblast Growth Factor 23 (R176Q) Delineate a Putative Role for Parathyroid Hormone in Renal Phosphate Wasting Disorders
Endocrinology, November 1, 2004; 145(11): 5269 - 5279.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Larsson, R. Marsell, E. Schipani, C. Ohlsson, O. Ljunggren, H. S. Tenenhouse, H. Juppner, and K. B. Jonsson
Transgenic Mice Expressing Fibroblast Growth Factor 23 under the Control of the {alpha}1(I) Collagen Promoter Exhibit Growth Retardation, Osteomalacia, and Disturbed Phosphate Homeostasis
Endocrinology, July 1, 2004; 145(7): 3087 - 3094.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
I. V. Silva, C. J. Blaisdell, S. E. Guggino, and W. B. Guggino
PTH regulates expression of ClC-5 chloride channel in the kidney
Am J Physiol Renal Physiol, February 1, 2000; 278(2): F238 - F245.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society